3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
21
Pancreatic Neoplasms
10
Colonic Neoplasms
9
Burkitt Lymphoma
8
Adenocarcinoma Of Esophagus
7
Stomach Neoplasms
6
Rectal Neoplasms
6
Neoplasm Metastasis
5
Esophageal Neoplasms
5
Cholangiocarcinoma
5
Carcinoma, Non-Small-Cell Lung
5
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
Neoplasms
4
Leukemia, Biphenotypic, Acute
4
Adenocarcinoma
4
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Lung Neoplasms
3
Gallbladder Neoplasms
3
Endometrial Neoplasms
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Ovarian Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Down Syndrome
2
Carcinoma, Hepatocellular
2
Advanced Solid Tumors
2
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Solid Tumors
1
Small Bowel Adenocarcinoma
1
Interventions
Cyclophosphamide
15
Rituximab
12
fludarabine
7
Specimen Handling
7
Magnetic Resonance Spectroscopy
7
fludarabine phosphate
6
obinutuzumab
5
X-Rays
5
Phantoms, Imaging
5
Biopsy
5
polatuzumab vedotin
4
pembrolizumab
4
ibrutinib
4
Whole-Body Irradiation
4
Prednisone
4
Nuclear Medicine Department, Hospital
4
Mycophenolic Acid
4
Lenalidomide
4
Cyclosporine
4
venetoclax
3
tocilizumab
3
Peripheral Blood Stem Cell Transplantation
3
Nivolumab
3
Leukapheresis
3
Gemcitabine
3
Etoposide
3
Doxorubicin
3
Dexamethasone
3
Busulfan
3
zanubrutinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Non-Hodgkin
×
Leucovorin
×
30 days
×
Clear all
No trials found.